Johnson & Johnson Innovation moves into Cambridge

Johnson & Johnson Innovation has handed the Cambridge UK medical technology cluster a further boost by taking space on the Babraham Research Campus.

It has formed a network of partnering offices across UK life science clusters as part of a broader strategy to interact more directly with life science ‘hotspots’ throughout the UK and Europe.

Babraham is already home to Imperial Innovations and the cluster is preparing the ground for AstraZeneca’s move to the Cambridge Biomedical Campus with 2,000 jobs created at its corporate and R & D functions.

Johnson & Johnson said the new network of offices will function as extensions of its London Innovation Centre to work with academics and entrepreneurs throughout the UK to identify early stage innovation and support the translation of research into new products for patients.

The other new network offices will be at the University of Oxford Old Road Campus for the wider Oxford area; the University of Manchester Innovation Centre (UMIC) for the North and Midlands; the Edinburgh BioQuarter for Scotland and Northern Ireland and the Life Sciences Hub Wales in Cardiff for Wales and the South West.

Representatives from the Johnson & Johnson Innovation Centre in London will establish a regular presence in each of the partnering offices that are expected to be fully operational in early 2014.

“Establishing these partnering offices reflects our commitment to collaborative innovation and our belief that being close to the source of innovation drives our ability to create strong networks of people who can combine ideas, resources and technologies in a new way to tackle urgent unmet medical needs,” said Patrick Verheyen, head of the Johnson & Johnson Innovation Centre, London.

Dr Kurt Hertogs, Incubator Strategy Leader for the Johnson & Johnson Innovation, London added: “Opening these new partnering offices extends the approach we piloted with Stevenage Bioscience Catalyst (SBC) earlier this year.

“Our continuing experience with SBC confirms this model as an effective way for our scientific teams to interact with innovators and entrepreneurs, and advance promising healthcare solutions.

“Given the number and diversity of research campuses, incubators, and life science parks throughout the UK and Europe, we believe the establishing of these regional partnering offices will enable us to reach out and more effectively collaborate with innovators across the UK and Europe.”

Please click here for original source.

Comments are closed.